03:29 PM EDT, 09/10/2025 (MT Newswires) -- Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index falling 0.8% and the Health Care Select Sector SPDR Fund (XLV) easing 1.1%.

The iShares Biotechnology ETF (IBB) dropped 1.9%.

In corporate news, Neurosense Therapeutics ( NRSN ) shares jumped more than 27% after the initial phase 2 trial results of PrimeC to treat Alzheimer's disease showed enhanced neuroplasticity and no treatment-related toxicity.